Literature DB >> 25997658

Pityriasis Rosea in Children: Clinical Features and Laboratory Investigations.

Francesco Drago1, Giulia Ciccarese, Francesco Broccolo, Emanuele Cozzani, Aurora Parodi.   

Abstract

Pityriasis rosea (PR) is a common, self-limiting exanthematous disease associated with a systemic reactivation of human herpesvirus 6 (HHV-6) and/or HHV-7. It usually occurs in the second or third decade of life whereas it is uncommon in patients younger than 10 years. We studied the clinical features and virological parameters of 31 children with PR, comparing them with those in adults. Our findings indicate that PR presents different characteristics between children and adults, mainly consisting of time lapse between herald patch and generalized eruption, duration of the exanthem, oropharyngeal involvement and persistence of HHV-6 and HHV-7 plasma viremia. Overall, these results suggest that, following HHV-6 and/or HHV-7 systemic active infection, the pathogenetic mechanisms involved in PR may at least partly be different in children and adults.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25997658     DOI: 10.1159/000381285

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  7 in total

1.  Interventions for pityriasis rosea.

Authors:  Jose Contreras-Ruiz; Sandra Peternel; Carlos Jiménez Gutiérrez; Ivana Culav-Koscak; Ludovic Reveiz; Maria de Lourdes Silbermann-Reynoso
Journal:  Cochrane Database Syst Rev       Date:  2019-10-30

2.  Concurrent pityriasis rosea and Bell's palsy.

Authors:  Vanessa Voss; Adam Mattox; Mary Guo
Journal:  BMJ Case Rep       Date:  2017-01-23

Review 3.  Clinical variants of pityriasis rosea.

Authors:  Francisco Urbina; Anupam Das; Emilio Sudy
Journal:  World J Clin Cases       Date:  2017-06-16       Impact factor: 1.337

4.  Higher Expression of Toll-like Receptors 3, 7, 8, and 9 in Pityriasis Rosea.

Authors:  Mostafa Abou El-Ela; Mohamed El-Komy; Rania Abdel Hay; Rehab Hegazy; Amin Sharobim; Laila Rashed; Khalda Amr
Journal:  J Pathol Transl Med       Date:  2017-02-13

5.  Pityriasis rosea in a patient with retrovirus infection: a reply.

Authors:  Giulia Ciccarese; Aurora Parodi; Francesca Drago; Astrid Herzum; Francesco Drago
Journal:  Postepy Dermatol Alergol       Date:  2018-02-20       Impact factor: 1.837

Review 6.  Effectiveness of acyclovir in the treatment of pityriasis rosea. A systematic review and meta-analysis.

Authors:  Milton Rodriguez-Zuniga; Natalie Torres; Herney Garcia-Perdomo
Journal:  An Bras Dermatol       Date:  2018 Sep-Oct       Impact factor: 1.896

7.  Efficacy and Safety of Indigo Naturalis in Combination with Narrow-Band Ultraviolet B for Treatment of Pityriasis Rosea: A Meta-Analysis.

Authors:  L Wang; Y N Xue; Z W Li; W Zhang; X P Ji; Z Fan; Y J Li
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-27       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.